High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.

[1]  V. Dato,et al.  National surveillance for human and pet contact with oral rabies vaccine baits, 2001-2009. , 2012, Journal of the American Veterinary Medical Association.

[2]  A. Amonsin,et al.  Prevalence of respiratory viruses isolated from dogs in Thailand during 2008-2009 , 2010 .

[3]  J. Arnemo,et al.  SEROSURVEY FOR CANINE DISTEMPER VIRUS, CANINE ADENOVIRUS, LEPTOSPIRA INTERROGANS, AND TOXOPLASMA GONDII IN FREE-RANGING CANIDS IN SCANDINAVIA AND SVALBARD , 2010, Journal of wildlife diseases.

[4]  Tiziana Lembo,et al.  The Feasibility of Canine Rabies Elimination in Africa: Dispelling Doubts with Data , 2010, PLoS neglected tropical diseases.

[5]  Timothy P. Algeo,et al.  Oral Rabies Vaccination in North America: Opportunities, Complexities, and Challenges , 2009, PLoS neglected tropical diseases.

[6]  D. Slate,et al.  Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. , 2009, Vaccine.

[7]  H. Ertl.  Novel Vaccines to Human Rabies , 2009, PLoS neglected tropical diseases.

[8]  L. Geue,et al.  Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria , 2009, Archives of Virology.

[9]  L. Geue,et al.  Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19 , 2009, Microbiology and immunology.

[10]  A. H. Kirmizigül,et al.  Seroprevalence of Canine Adenovirus (CAV) Infection in Kars Dogs in Turkey , 2009 .

[11]  R. Atlas,et al.  Meeting the rabies control challenge in South Africa , 2009 .

[12]  S. Cleaveland,et al.  Rabies control in rural Africa: evaluating strategies for effective domestic dog vaccination. , 2009, Vaccine.

[13]  A. Fooks,et al.  Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. , 2008, Vaccine.

[14]  S. Nadin-Davis,et al.  ERA VACCINE-DERIVED CASES OF RABIES IN WILDLIFE AND DOMESTIC ANIMALS IN ONTARIO, CANADA, 1989–2004 , 2008, Journal of wildlife diseases.

[15]  D. Slate,et al.  Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization , 2008, BMC Immunology.

[16]  B. Pattnaik,et al.  The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. , 2007, Vaccine.

[17]  C. Rupprecht,et al.  Emergence of lyssaviruses in the Old World: the case of Africa. , 2007, Current topics in microbiology and immunology.

[18]  M. Schnell,et al.  A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. , 2006, Virology.

[19]  S. Cleaveland,et al.  Canine vaccination--providing broader benefits for disease control. , 2006, Veterinary microbiology.

[20]  A. Fooks,et al.  Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. , 2006, Microbes and infection.

[21]  M C Schneider,et al.  Overview of rabies in the Americas. , 2005, Virus research.

[22]  D. Slate,et al.  Status of oral rabies vaccination in wild carnivores in the United States. , 2005, Virus research.

[23]  W. J. Müller,et al.  Prevalence of serum antibodies to canine adenovirus and canine herpesvirus in the European red fox (Vulpes vulpes) in Australia. , 2005, Australian veterinary journal.

[24]  T. Kuiken,et al.  Antibodies to selected pathogens in free-ranging terrestrial carnivores and marine mammals in Canada , 2004, Veterinary Record.

[25]  A. Hasted,et al.  Serum antibody titres to canine parvovirus, adenovirus and distemper virus in dogs in the UK which had not been vaccinated for at least three years , 2004, Veterinary Record.

[26]  M. Aubert,et al.  Elimination of terrestrial rabies in Western European countries. , 2004, Developments in biologicals.

[27]  Z. Xiang,et al.  Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier , 2003, Journal of Virology.

[28]  J. D. du Toit,et al.  Seroconversion in captive African wild dogs (Lycaon pictus) following administration of a chicken head bait/SAG-2 oral rabies vaccine combination. , 2003, The Onderstepoort journal of veterinary research.

[29]  L. Fischer,et al.  Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge. , 2002, Vaccine.

[30]  C. Hanlon,et al.  Oral Efficacy of an Attenuated Rabies Virus Vaccine in Skunks and Raccoons , 2002, Journal of wildlife diseases.

[31]  T. Mueller,et al.  Field trial with oral vaccination of dogs against rabies in the Philippines , 2001, BMC infectious diseases.

[32]  C. Hanlon,et al.  Human infection due to recombinant vaccinia-rabies glycoprotein virus. , 2001, The New England journal of medicine.

[33]  J. Bingham,et al.  Presence of antibodies to canine distemper virus, canine parvovirus and canine adenovirus type 1 in free-ranging jackals (Canis adustus and Canis mesomelas) in Zimbabwe. , 1999, The Onderstepoort journal of veterinary research.

[34]  J. Bingham,et al.  Efficacy of SAG-2 oral rabies vaccine in two species of jackal (Canis adustus and Canis mesomelas). , 1999, Vaccine.

[35]  T. Hulland.  A Biographical History of Veterinary Pathology , 1997 .

[36]  J. Childs,et al.  Molecular epidemiology of rabies in the United States: reemergence of a classical neurotropic agent. , 1995, Journal of neurovirology.

[37]  M. Artois,et al.  Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe. , 1996, Vaccine.

[38]  J. Shaddock,et al.  Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs. , 1996, Vaccine.

[39]  S. Mainka,et al.  Serologic Survey of Giant Pandas (Ailuropoda melanoleuca), and Domestic Dogs and Cats in the Wolong Reserve, China , 1994, Journal of wildlife diseases.

[40]  A. Flamand,et al.  SAG-2 oral rabies vaccine. , 1993, The Onderstepoort journal of veterinary research.

[41]  C. Rupprecht,et al.  Experimental Oral Administration of Canine Adenovirus (Type 2) to Raccoons (Procyon lotor) , 1992, Veterinary pathology.

[42]  C. Rupprecht,et al.  PREREQUISITES FOR ORAL IMMUNIZATION OF FREE-RANGING RACCOONS (PROCYON LOTOR) WITH A RECOMBINANT RABIES VIRUS VACCINE: STUDY SITE ECOLOGY AND BAIT SYSTEM DEVELOPMENT , 1992, Journal of wildlife diseases.

[43]  Å. Hedhammar,et al.  Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden. , 1988, American journal of veterinary research.

[44]  G. Baer,et al.  Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose. , 1988, American journal of veterinary research.

[45]  F. Brown,et al.  Control of Wildlife Rabies , 1985 .

[46]  A. Osterhaus,et al.  Antiviral Antibodies in Dogs in the Netherlands , 1977, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[47]  D. Robson,et al.  Canine adenovirus type 2-induced immunity to two canine adenoviruses in pups with maternal antibody. , 1975, American journal of veterinary research.

[48]  M. Menegus,et al.  Pathogenicity of low-virulence strains of two canine adenovirus types. , 1973, American journal of veterinary research.

[49]  L. Binn,et al.  A comparison of the pathogenesis and antigenicity of infectious canine hepatitis virus and the A26-61 virus strain (Toronto). , 1970, Journal of the American Veterinary Medical Association.